β(2) -Glycoprotein I: evolution, structure and function.
about
The role of the gut microbiota in the pathogenesis of antiphospholipid syndromeObstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsEffect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL)-mediated inhibition of endometrial angiogenesisContamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I).Is atherosclerosis an autoimmune disease?An A1-A1 mutant with improved binding and inhibition of β2GPI/antibody complexes in antiphospholipid syndrome."New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndromeReduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathwayReduced beta 2 glycoprotein I improve diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathwayIdentification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.Antiphospholipid-related chorea.A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approachEvaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndromeHuman plasma protein N-glycosylationThiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment.Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndromeInhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndromeGuidelines on the investigation and management of antiphospholipid syndrome.Recent developments in our understanding of the antiphospholipid syndrome.Pathophysiology of thrombotic APS: where do we stand?The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndromeHigh expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection.Chronic exposure to oral pathogens and autoimmune reactivity in acute coronary atherothrombosis.The Laboratory Diagnosis of the Antiphospholipid Syndrome.Pathogenesis and management of antiphospholipid syndrome.Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity.Βeta 2-glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner.Plasmodium berghei EXP-1 interacts with host Apolipoprotein H during Plasmodium liver-stage development.Evaluation of three fully automated immunoassay systems for detection of IgA anti-beta 2-glycoprotein I antibodies.Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools.Dimerized Domain V of Beta2-Glycoprotein I Is Sufficient to Upregulate Procoagulant Activity in PMA-Treated U937 Monocytes and Require Intact Residues in Two Phospholipid-Binding Loops.A new trick for an ancient drug: quinine dissociates antiphospholipid immune complexes.Reduced beta 2 glycoprotein I prevents high glucose-induced cell death in HUVECs through miR-21/PTEN.Identification of the binding site for fondaparinux on Beta2-glycoprotein I.Platelets as pivot in the antiphospholipid syndrome.Genetic determinants of plasma β₂-glycoprotein I levels: a genome-wide association study in extended pedigrees from Spain.Development of a new parallelized, optical biosensor platform for label-free detection of autoimmunity-related antibodies.Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus.
P2860
Q26866133-5D14204C-FAB3-41F7-BFC2-D7A7C417FBF5Q26998188-4C592357-A157-4B10-9C1E-37FA572E5E60Q28740531-1CE88D93-F101-4726-9551-E4BEB03685CEQ35019430-CF4A9535-5C5D-409E-8CC5-4F8C3CEA0177Q35123740-303D4730-63FE-4649-B13A-4FF9A89E95A1Q35152055-D6B7A451-08D3-41CB-BBFC-E0EB7C613446Q35250419-44D00447-16C5-4A85-88B6-8D54D659E32AQ35631986-BE87D40F-72E3-4262-B943-ED383858D7CAQ35870605-C9998290-FADB-49C6-9E6B-0E40E1D958D1Q36087118-093EB2D3-67B0-4152-A0E5-207AAE6EF68AQ36337350-B75FE9A3-5553-4A8E-92D0-524AE716D55EQ36547962-6F87FA09-D30A-4EF1-AC37-3267CEB641E4Q36774243-BD909AF5-64D6-4894-8249-C38E46564E68Q36963945-373BE201-AC26-408F-8FB4-94CC8A479E02Q36984552-9E37731A-9040-4428-ADF0-523BEB82AB0AQ37204282-2CC039D7-952E-4DE6-A516-92F3F6F162C0Q37585221-D6714B5D-B8CC-4CEC-B5A2-C2CFF22884DCQ37982121-3D1B4228-73B7-457C-BC9F-234CAA8591D9Q37991066-00A9279E-BC56-4F71-803B-AA37B741242CQ38013582-4866DB99-37C8-483F-AF82-F14169FC1821Q38158240-06520BD6-9E5F-43D7-820E-4B2C09670461Q38986713-8B9952C6-9F6C-462F-A5E1-99BFA1CB54FAQ39001579-5C8B5A3B-62A8-4B02-B053-3F291FE62D30Q39036651-BAD70A97-FCFE-4DFB-AF58-D390CB8D1F47Q39134202-15AF52F5-86B7-4915-A265-F00845EBA720Q39198671-C2873965-092C-4FFC-AAB8-D8BC3565E484Q40059466-38261A7E-B787-4005-93E7-6D39E3656701Q40092025-18BFC525-6BE6-4274-8162-39D404D37BCBQ40352780-01F3B10E-5868-442A-99C9-3BBF8498C683Q40643063-CCFD24D3-A28F-4654-B0B7-237F29EF92BFQ40649226-36F6DE14-0BDC-498D-AEB1-2E211BE190E9Q41103646-77A751E2-C117-42D5-BECA-A2F0DF0B8EACQ41920381-43607B1F-C03E-4193-B941-E7168A6A833EQ42106760-673229D4-61F1-4CB6-8737-F06F0E9A6677Q42630208-85B7D91D-7EC9-4D36-94B2-2DA8DA390312Q42748299-94B590E0-16FA-4793-9718-E9C1A72849D6Q43526508-3CB54103-9EDA-48E1-AC9D-97315B095D4DQ44618214-FAC83261-C64E-454F-AD3A-BB53A926400AQ46483595-FD82D890-1A41-4F7C-9607-13A5EDE5CA59Q46586191-755F9FD0-CC73-41C4-9518-818AD16BA331
P2860
β(2) -Glycoprotein I: evolution, structure and function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
β(2) -Glycoprotein I: evolution, structure and function.
@en
β(2) -Glycoprotein I: evolution, structure and function.
@nl
type
label
β(2) -Glycoprotein I: evolution, structure and function.
@en
β(2) -Glycoprotein I: evolution, structure and function.
@nl
prefLabel
β(2) -Glycoprotein I: evolution, structure and function.
@en
β(2) -Glycoprotein I: evolution, structure and function.
@nl
P2860
P1476
β(2) -Glycoprotein I: evolution, structure and function
@en
P2093
P G de Groot
P2860
P304
P356
10.1111/J.1538-7836.2011.04327.X
P50
P577
2011-07-01T00:00:00Z